Efficacy and Safety of OnceWeekly Semaglutide Versus Once-Daily Insulin Glargine as Add On to Metformin (with or without Sulfonylureas) in Insulin-Naive Patients with Type 2 Diabetes (SUSTAIN 4): A Randomised, OpenLabel, Parallel-Group, Multicentre, Multinational, Phase 3a Trial
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the treatment of obesity and type 2 diabetes mellitus (T2DM) by mimicking endogenous GLP-1 activity, increasing glucose-dependent insulin secretion and suppressing glucagon release
So, this is showing a lot of promise there. Should you consider taking retatrutide
Stop fighting biology
Appetite suppression is often strongest in the first part of the day, and many patients tell me they're simply not hungry which creates a real risk of under-eating protein and starting the day in a deficit they don't recover from by dinner
This creates a 5mg/mL concentration with excellent readability at the lower dose levels